Omni Bio Announces First Infusion in Phase I/II Clinical Trial

Omni Bio Pharmaceutical, Inc. Monday announced that the first patient has been infused in its FDA-cleared Phase I/II human clinical trial of Alpha-1 antitrypsin in recently diagnosed Type 1 diabetics.
FreshNews